Testosterone 's Effects on Atherosclerosis Progression in Aging Men ( TEAAM ) was a placebo-controlled , double-blind , parallel-group randomized trial involving 308 men 60 years or older with low or low-normal testosterone levels ( 100-400 ng/dL ; free testosterone < 50 pg/mL ) , recruited at 3 US centers .